Shanghai BaiO Technology Corp. (“BaiO Technology”) (Company Code: 430353) was successfully listed on the National Equities Exchange and Quotations (“NEEQ”) on 13 November, 2014.

BaiO Technology is engaged in the development, production, and sales of the genetic diagnosis products and its support equipment of the clinical individualized medication.

In this listing, Cinda Securities Corp. acted as the sponsor, Li & Partners (Beijing) acted as the legal adviser.